[EN] USE OF NEP INHIBITORS FOR THE TREATMENT OF GASTROINTESTINAL SPHINCTER DISORDERS<br/>[FR] UTILISATION D'INHIBITEURS DE NEP POUR LE TRAITEMENT DE TROUBLES DU SPHINCTER GASTRO-INTESTINAL
申请人:[en]CURTAILS LLC
公开号:WO2022265984A1
公开(公告)日:2022-12-22
The present disclosure relates to methods, uses, pharmaceutical compositions and kits comprising an NEP inhibitor or a pharmaceutically acceptable salt thereof, alone or in combination with one or more additional therapeutic agents, for the treatment of a gastrointestinal sphincter disorder. Gastrointestinal sphincter disorders include, but are not limited to, achalasia and other hypertensive or spastic sphincter disorders elsewhere in the gastrointestinal tract or sphincter spasms, or hypertensive sphincter disorders of the gastrointestinal tract.